St Jude Medical
STJ
STJ was delisted on the 4th of January, 2017.
615 hedge funds and large institutions have $19B invested in St Jude Medical in 2016 Q2 according to their latest regulatory filings, with 131 funds opening new positions, 161 increasing their positions, 242 reducing their positions, and 81 closing their positions.
367% more funds holding in top 10
Funds holding in top 10: 9 → 42 (+33)
62% more first-time investments, than exits
New positions opened: 131 | Existing positions closed: 81
45% more capital invested
Capital invested by funds: $13.1B → $19B (+$5.88B)
31% more call options, than puts
Call options by funds: $54.8M | Put options by funds: $41.8M
8% more funds holding
Funds holding: 570 → 615 (+45)
33% less repeat investments, than reductions
Existing positions increased: 161 | Existing positions reduced: 242
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$474M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$328M |
| 3 |
Citigroup
New York
|
+$321M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$299M |
| 5 |
Morgan Stanley
New York
|
+$285M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.43B |
| 2 |
Royal London Asset Management
United Kingdom
|
-$264M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$205M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$172M |
| 5 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$164M |
STJ Hedge Fund Activity: Q2 2016 in Review
615 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q2 2016, worth a combined $19B — up 45% from $13.1B a quarter earlier.
Buyers outnumbered sellers: 131 funds opened new STJ positions and 81 closed out — a net gain of 50 holders — while 161 added to existing stakes and 242 trimmed.
The largest buyer was Franklin Resources, adding an estimated $474M. The largest seller was Capital Research Global Investors, cutting an estimated $1.43B.
- 615 institutional investors held St Jude Medical (STJ) as of Q2 2016, up from 570 in Q1 2016.
- Funds reported $19B of St Jude Medical stock for Q2 2016, up 45% quarter-over-quarter.
- 131 funds opened new St Jude Medical positions in Q2 2016 and 81 closed out, a net change of +50 holders.
- The largest St Jude Medical buyer in Q2 2016 was Franklin Resources, an estimated $474M added.
- The largest St Jude Medical seller in Q2 2016 was Capital Research Global Investors, an estimated $1.43B sold.
Based on aggregated 13F filings for Q2 2016.